Stéphanie Rolin

875 total citations
29 papers, 721 citations indexed

About

Stéphanie Rolin is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Stéphanie Rolin has authored 29 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Molecular Biology. Recurrent topics in Stéphanie Rolin's work include Inflammatory mediators and NSAID effects (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Synthesis and Catalytic Reactions (5 papers). Stéphanie Rolin is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Synthesis and Catalytic Reactions (5 papers). Stéphanie Rolin collaborates with scholars based in Belgium, Italy and Romania. Stéphanie Rolin's co-authors include Bernard Masereel, Andrea Scozzafava, Claudiu T. Supuran, Jean-Michel Dogné, Jean‐Michel Dogné, Francesco Abbate, Xavier de Leval, J. Delarge, Catherine Michaux and Bernard Pirotte and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Stéphanie Rolin

29 papers receiving 701 citations

Peers

Countries citing papers authored by Stéphanie Rolin

Since Specialization

Citations

This map shows the geographic impact of Stéphanie Rolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Rolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Rolin more than expected).

Fields of papers citing papers by Stéphanie Rolin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Rolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Rolin. The network helps show where Stéphanie Rolin may publish in the future.

Co-authorship network of co-authors of Stéphanie Rolin

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Rolin. A scholar is included among the top collaborators of Stéphanie Rolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Rolin. Stéphanie Rolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A comparison of six major platelet functional tests to assess the impact of carbon nanomaterials on platelet function: A practical guide 2013 ·Nanotoxicology ·Julie Laloy, François Mullier, (unknown), Jorge Mejia, Stéphane Lucas, Bernard Châtelain, Olivier Toussaint, Bernard Masereel, Stéphanie Rolin, Jean‐Michel Dogné	10
2	Effects of SiC nanoparticles orally administered in a rat model: Biodistribution, toxicity and elemental composition changes in feces and organs 2012 ·Toxicology and Applied Pharmacology ·Omar Lozano, Julie Laloy, (unknown), Jorge Mejia, Stéphanie Rolin, Olivier Toussaint, Jean‐Michel Dogné, Stéphane Lucas, Bernard Masereel	24
3	Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials 2011 ·Nanotoxicology ·Julie Laloy, Séverine Robert, (unknown), François Mullier, Jorge Mejia, Jean‐Pascal Piret, Stéphane Lucas, Bernard Châtelain, Jean‐Michel Dogné, Olivier Toussaint, Bernard Masereel, Stéphanie Rolin	21
4	Synthesis and pharmacological evaluation of a new targeted drug carrier system: β-Cyclodextrin coupled to oxytocin 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Stéphanie Rolin, Brigitte Évrard, Lionel Pochet, Bernard Masereel	17
5	Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: Structure–activity relationship and pharmacological evaluation 2008 ·European Journal of Medicinal Chemistry ·Anne Thiry, Stéphanie Rolin, Daniela Vullo, (unknown), Andrea Scozzafava, Jean‐Michel Dogné, Johan Wouters, Claudiu T. Supuran, Bernard Masereel	19
6	BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2α in vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodents 2007 ·Prostaglandins & Other Lipid Mediators ·Stéphanie Rolin, Julien Hanson, (unknown), (unknown), Domenico Praticò, Bernard Masereel, (unknown)	8
7	Prostanoids as pharmacological targets in COPD and asthma 2006 ·European Journal of Pharmacology ·Stéphanie Rolin, Bernard Masereel, Jean-Michel Dogné	72
8	Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion 2005 ·Prostaglandins & Other Lipid Mediators ·Philippe Kolh, Stéphanie Rolin, Vincent Tchana‐Sato, Michel Pétein, Alexandre Ghuysen, Bernard Lambermont, Julien Hanson, David Magis, Patrick Segers, Bernard Masereel, Vincent D’Orio, Jean‐Michel Dogné	4
9	Synthesis, molecular modelling and enzymatic evaluation of (±)3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitors 2005 ·Bioorganic & Medicinal Chemistry ·(unknown), Catherine Michaux, Stéphanie Rolin, (unknown), Xavier de Leval, Fabien Julémont, Lionel Pochet, Bernard Masereel	16
10	In Vitro and in Vivo Pharmacological Characterization of BM-613 [N-n-Pentyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a Novel Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Julien Hanson, Stéphanie Rolin, Dénis Reynaud, Na Qiao, (unknown), Helen M. Reid, (unknown), John R. Tippins, B. Therese Kinsella, Bernard Masereel, C.R. Pace-Asciak, Bernard Pirotte, Jean-Michel Dogné	11
11	Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig 2005 ·Thrombosis Research ·Jean‐Michel Dogné, Stéphanie Rolin, Michel Pétein, Vincent Tchana‐Sato, Alexandre Ghuysen, Bernard Lambermont, Julien Hanson, David Magis, Patrick Segers, Bernard Pirotte, Bernard Masereel, Pierre Drion, Vincent D’Orio, Philippe Kolh	18
12	Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors 2004 ·Prostaglandins & Other Lipid Mediators ·Stéphanie Rolin, Jean‐Michel Dogné, (unknown), Julien Hanson, Bernard Masereel	1
13	Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Jean‐Michel Dogné, Julien Hanson, Xavier de Leval, Philippe Kolh, Vincent Tchana‐Sato, Laurence de Leval, Stéphanie Rolin, Alexandre Ghuysen, Patrick Segers, Bernard Lambermont, Bernard Masereel, Bernard Pirotte	24
14	Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity 2004 ·Bioorganic & Medicinal Chemistry ·Marc A. Ilies, Bernard Masereel, Stéphanie Rolin, Andrea Scozzafava, (unknown), Valentin Cı̂mpeanu, Claudiu T. Supuran	75
15	Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Bernard Masereel, Stéphanie Rolin, Anne Thiry, Andrea Scozzafava, Alessio Innocenti, Claudiu T. Supuran	31
16	A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors 2003 ·European Journal of Medicinal Chemistry ·Catherine Michaux, Jean‐Michel Dogné, Stéphanie Rolin, Bernard Masereel, Johan Wouters, F. Durant	5
17	BM-573, a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, Prevents Pig Myocardial Infarction Induced by Coronary Thrombosis 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Stéphanie Rolin, M. Petein, Vincent Tchana‐Sato, Jean‐Michel Dogné, P Benoît, (unknown), Alexandre Ghuysen, P. Kolh, Bernard Masereel	23
18	Activity of a novel dual thromboxane A2receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles 2001 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Stéphanie Rolin, Jean‐Michel Dogné, Catherine Michaux, J. Delarge, Bernard Masereel	29
19	Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition 2001 ·Bioorganic & Medicinal Chemistry Letters ·Catherine Michaux, Stéphanie Rolin, Jean‐Michel Dogné, F. Durant, Bernard Masereel, J. Delarge, Johan Wouters	10
20	Pharmacology of the Thromboxane Receptor Antagonist and Thromboxane Synthase Inhibitor BM‐531 2001 ·Cardiovascular Drug Reviews ·Jean‐Michel Dogné, Stéphanie Rolin, Xavier de Leval, (unknown), P. Neven, J. Delarge, Philippe Kolh, J. Damas, Jean‐Louis David, Bernard Masereel	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact